IIH Intervention: A Clinical Trial Comparing 2 Treatments (Shunts and Stents) Evaluation Of Clinical Effectiveness And Cost Effectiveness

Idiopathic Intracranial Hypertension (IIH) is a condition that affects the brain, specifically causing high pressure inside your skull. This increased pressure can lead to symptoms like persistent headaches, blurred vision, and a pulsing sound in your ears. It is more commonly found in women of childbearing age who are overweight. The good news is that for most people with IIH, managing their weight and taking specific medicines can help control the condition. However, for a small number of people, the vision can get worse quickly, and they need an urgent treatment to lower this pressure and protect their eyesight.

This study, called "IIH Intervention", is looking at two common procedures used in the UK for these urgent cases: CSF shunting and dural venous sinus stenting (DVSS). Shunting involves a small operation to put a thin tube into your body to gently drain away some of the fluid around your brain. Stenting is a procedure where a small, mesh tube is placed inside a blood vessel in your brain to help it stay open. Both of these treatments are already being used, but doctors don't yet have enough information to say which one is consistently better at saving vision and more cost-effective for the NHS. This research hopes to provide that important information by comparing these two treatments directly.

By taking part, you would be helping researchers discover which of these existing treatments offers the most benefit to patients with IIH who are at risk of losing their sight. The aim is to genuinely improve how people with this condition are treated in the future, helping to ensure that the most effective and efficient care is provided across the UK.